INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD enters LYELL IMMUNOPHARMA, INC. with 3M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 6/18/2026ACC: 0001140361-26-025740
→
10% Owner
Since Jun 2026
3M
Baseline shares
100% direct
3M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned3M
Total
3M direct3M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3M | Direct |
| Total | 3M | 3M direct |
Derivative Holdings0
No derivative holdings reported